학술논문

Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
Document Type
Report
Author
C Yuen, Ryan KMerico, DanieleBookman, MattL Howe, JenniferThiruvahindrapuram, BhoomaPatel, Rohan VWhitney, JoeDeflaux, NicoleBingham, JonathanWang, ZhuozhiPellecchia, GiovannaBuchanan, Janet AWalker, SusanMarshall, Christian RUddin, MohammedZarrei, MehdiDeneault, EricD'Abate, LiaChan, Ada J SKoyanagi, StephaniePaton, TaraPereira, Sergio LHoang, NyEngchuan, WorrawatHigginbotham, Edward JHo, KarenLamoureux, SylviaLi, WeiliMacDonald, Jeffrey RNalpathamkalam, ThomasSung, Wilson W LTsoi, Fiona JWei, JohnXu, LizhenTasse, Anne-MarieKirby, EmilyVan Etten, WilliamTwigger, SimonRoberts, WendyDrmic, IreneJilderda, SanneModi, Bonnie MacKinnonKellam, BarbaraSzego, MichaelCytrynbaum, CherylWeksberg, RosannaZwaigenbaum, LonnieWoodbury-Smith, MarcBrian, JessicaSenman, LiliIaboni, AlanaDoyle-Thomas, KrissyThompson, AnnChrysler, ChristinaLeef, JonathanSavion-Lemieux, TalSmith, Isabel MLiu, XudongNicolson, RobSeifer, VickiFedele, AngieCook, Edwin HDager, StephenEstes, AnnetteGallagher, LouiseMalow, Beth AParr, Jeremy RSpence, Sarah JVorstman, JacobFrey, Brendan JRobinson, James TStrug, Lisa JFernandez, Bridget AElsabbagh, MayadaCarter, Melissa THallmayer, JoachimKnoppers, Bartha MAnagnostou, EvdokiaSzatmari, PeterRing, Robert HGlazer, DavidPletcher, Mathew TScherer, Stephen W
Source
Nature Neuroscience. April 2017, Vol. 20 Issue 4, p602, 10 p.
Subject
Psychological aspects
Innovations
Genetic aspects
Risk factors
Health aspects
Genotypes -- Health aspects -- Psychological aspects
Molecular targeted therapy -- Innovations
Pervasive developmental disorders -- Genetic aspects -- Risk factors
Language
English
ISSN
1097-6256
Abstract
Author(s): Ryan K C Yuen [1]; Daniele Merico [1, 2]; Matt Bookman [3, 4]; Jennifer L Howe [1]; Bhooma Thiruvahindrapuram [1]; Rohan V Patel [1]; Joe Whitney [1]; Nicole Deflaux [...]
We are performing whole-genome sequencing of families with autism spectrum disorder (ASD) to build a resource (MSSNG) for subcategorizing the phenotypes and underlying genetic factors involved. Here we report sequencing of 5,205 samples from families with ASD, accompanied by clinical information, creating a database accessible on a cloud platform and through a controlled-access internet portal. We found an average of 73.8 de novo single nucleotide variants and 12.6 de novo insertions and deletions or copy number variations per ASD subject. We identified 18 new candidate ASD-risk genes and found that participants bearing mutations in susceptibility genes had significantly lower adaptive ability (P = 6 x 10[sup.-4]). In 294 of 2,620 (11.2%) of ASD cases, a molecular basis could be determined and 7.2% of these carried copy number variations and/or chromosomal abnormalities, emphasizing the importance of detecting all forms of genetic variation as diagnostic and therapeutic targets in ASD.